We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
Vicotex

Download Mobile App




New Studies to Focus on Prion Diseases

By Biotechdaily staff writers
Posted on 12 Nov 2002
The US Department of Health and Human Services (HHS, Washington, DC, USA) is commissioning studies of chronic wasting disease (CWD) in an effort to combat the spread of the disease in deer and elk herds across the country, to design better diagnostics and therapies, and to learn more about whether CWD and other prion diseases can be transmitted to humans. More...


CWD is one form of a group of fatal brain diseases called transmissible spongiform encephalopathies (TSEs). These diseases include bovine spongiform encephalopathy (BSE or mad cow disease) in cattle, scrapie in sheep, and Creutzfeldt-Jakob disease in humans. The hallmark of TSE disease is accumulation in the brain of abnormal prion proteins. Scientists do not know yet whether deer or elk with CWD might also transmit
some form of TSE disease to people who eat or have close contact with them.

"We must determine whether CWD is a threat to our food supply and how best to stop the spread of this disease in our deer and elk herds,” said HSS Secretary Tommy G. Thompson. "We will aggressively pursue innovative methods to expand research and direct assistance to states to fight the spread of CWD.”

Researchers will investigate the mechanics of CWD infection in deer and elk, especially in the immune system's lymphoid tissues, to aid the search for improved diagnostics and therapies. The researchers also will seek to better understand the entire spectrum of disease transmission and under what circumstances CWD might "jump” to other species. In addition, scientists will work on a possible vaccine to prevent the spread of CWD in deer and elk.

Scientists at the Rocky Mountain Laboratory (RML, Hamilton, Montana) of the US National Institute of Allergy and Infectious Diseases plan to investigate whether the abnormal CWD prion protein, presumed to be the agent that causes the disease, can be transmitted from deer or elk to monkeys if the monkeys eat meat containing the abnormal prion proteins. That knowledge would provide valuable insight into whether or not CWD could be transmitted to humans. Recently, RML scientists established that another TSE disease, hamster scrapie, could jump species--adapting to and causing disease in mice.

RML scientists also are collaborating with other researchers to test several new compounds, developed by NIAID scientists, that show promise in blocking the formation of abnormal prion proteins and therefore may one day be used as therapies to treat CWD or other TSE diseases. Some of these compounds may be able to decontaminate meat or other products infected with abnormal prion proteins.





Related Links:
US Department of Health and Human Services

Platinum Member
Automated Coagulation Analyzer
Hemolumi H6
Gold Member
Flocked Fiber Swabs
Puritan® Patented HydraFlock®
New
Gold Member
Fully-auto Specific Protein (Nephelometry) Analyzer
PA240
All-in-One Molecular System
AIO M160
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: Alzheimer’s pathology can start 15 to 20 years before symptoms, and validated tools that reach patients earlier help pave the way for earlier detection. (Image Credit: Adobe Stock)

Alzheimer’s Blood Test Becomes First FDA-Cleared Option for Adults as Young as 40

C2N Diagnostics’ PrecivityAD2 blood test was cleared by the U.S. Food and Drug Administration (FDA) on August 20, 2026, for adults as young as 40 who are experiencing signs of cognitive impairment, according... Read more

Pathology

view channel
Image: Adrenal gland tumor stained with hematoxylin and eosin (top) and CYP11B2 (bottom) (Photo courtesy of Christofer Juhlin)

Simple Immunohistochemical Size Ratio Improves Classification of Primary Aldosteronism

Primary aldosteronism is a common but underdiagnosed cause of hypertension, in which excess aldosterone promotes salt retention and raises blood pressure. Identifying the dominant source of hormone overproduction... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.